$ABBV with a Neutral outlook following its earnings #Stocks The PEAD projected a Neutral outlook for $ABBV after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 100%.
ABBVD trade ideas
ABBV is bull flaggingFrom B to C is not quite 61.8% retrace from flagpole high, but close enough.. B to C forms a nice bull flag, a continuation of primary trend. The breakout should occur at the mid line of the longer term upward channel. A 1.27 extension should give a target of 187 around Feb. 13 2023.
Healthcare (in addition to energy) is one of few sectors currently showing promise. Earnings on 10/28/22, Friday.
ABBV: some upside potential?A price action above 138.00 supports a bullish trend direction.
Crossing below this level wil negate the bullish stance.
Consolidation price range between 140.00 to 144.00
Crossing above this level will assist the bullish trend to target 149.00
Crossing below 140.00 will be the first sign of pending weakness.
ABBVmany Health Technologies went down .. Is ABBV lagging behind?
the triangle makes sense, the trendline makes sense and the volumes too
ABBV back above EMA200Great reversal af double bottom support.
Reversed back above EMA200 making a short term golden cross.
Waterfall on AbbVie. ABBVBetting on a further crash in AbbVie stock price. That huge candle preempts formal volatility switch. Fractally, hard to tell from this picture, possibly a start of a C in a WXY pattern.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
RectangleNeutral pattern.
ABBV pays a good yield and is still above the .382.
Possible inverse H&S inside the rectangle. If so the neckline in orange. If ABBV broke this line, a 100% move would take it to the top of the rectangle, or the resistance line.
EPS (FWD)
13.86
PE (FWD)
10.13
Div Rate (FWD)
$5.64
Yield (FWD)
4.02%
Short Interest
0.64%
Market Cap
$250.66B
No recommendation
AbbVie. Waiting for an exit from uptrendAbbVie Inc.
Idea: Long
Horizon: 1-2 months
Target: $145
Entry range: $143-145
Stop order: $141
Technical analysis
The share price has formed a short-term uptrend. If the local resistance level is broken through, there is a potential to move higher. Idea to increase the stock with the target of $145.
Fundamental factor
AbbVie is an American biopharmaceutical company founded in 2013 by a spinoff from Abbott Laboratories. One of the largest pharmaceutical companies in the world. Healthcare is a classic defensive sector in times of stock market turbulence. Given the high likelihood of continued serious tightening of monetary policy by the Fed, investors are shifting funds from interest-rate-dependent sectors to more stable ones. AbbVie's broadly diversified portfolio of drugs and products makes it one of the best candidates for this strategy.
ABBV to 147?I am really liking @abbv right now. That's a nice support level and for the size of that candle it did not have a strong volume. In my opinion @ABBV is consolidating. It's creating a compression on that gray area. ORRRRR is creating and inverted Head And Shoulder? Green line
ANY THOUGHTS?
"This is only my personal opinion. I am not a trading/finance adviser"
Short $ABBV from 144.25$ABBV at top of channel, but still trending down. RSI and MACD starting to round and point downwards. I hope to catch 144.25 on a positive day for markets this week.
Entry: 144.25
TP: 123,62
SL: 150,6
Falling Wedge on the dailyOur AbbVie is trying to break out of the "Falling Wedge" pattern but is having a hard time.
Despite the pattern resistance being broken, momentum is weakening (MACD).
In addition, the volume is nearly average.
It is the opposite of what we want to see when we expect a breakout from a 222-day pattern.
It is probably due to bearish market sentiment.
Given the situation, I have marked the two possible scenarios on the graph.
1. Scenario: overall market turns bullish.
In this case, there is a chance for continuation with a target price of 151.72.
2. Scenario: market keeps dipping.
I expect a false outbreak. In this case, we could easily visit the 131.18 level.
Support: 141.88, 141, 137.55, 131.18
Resistance: 147.4, 150.78, 151.87
RectangleATH 179.51
3 year low 62.55.
Yearly low 105.56
Earnings 10-28 BMO
No recommendation.
Strong stock with a good yield and is still above the .382 of the long trend up.
EPS (FWD)
13.86
PE (FWD)
10.39
Div Rate (FWD)
$5.64
Yield (FWD)
3.92%
Short Interest
0.64%
Market Cap
$254.71B
ABBV up;respecting wma50 despite LABU biotech 3x etf falling 10%ABBV is one of Warren Buffet’s holding in BRK.B. It has been respecting the weekly wma50 for a long time while holding an uptrend.
I think the sentiment has been too bearish & a shortterm rebound in the general market is due in the next few days.
Not trading advice.3
ABBV to $14&?Dammmmm what a day!!! I honestly don't see anything stopping @ABBV to hit the $147.~ area!. That some good and nice volume today. Nice candle in general. HOWEVER, I would like if @abbv re-test the trend line or the $140.~area. that would be nice and stronger (PO).
take a look at the related link!
ABBV Whats next?I LOVE today's candle.
1. Inside candle
2. indecision candle
3. with a nice volume
4. creating higher highs
5. forming a triangle
6. re-testing the trend line
7. re-testing the neck line if the w
8D. Its like compression at 10000%. Just waiting to see what @ABBV is gonna do!!!
Equity Seasonality and Bear Market Sector and Stock Selection Seasonalities are regular and predictable patterns that recur every calendar year. Every industry exhibits unique seasonal trends that are based on fundamental drivers. The best-known seasonal drivers include harvest periods, the timing of interest payments, weather, and investor sentiment. At certain times of the year, tax and balance sheet deadlines, annual or quarterly financial reports, as well as traditional patterns, such as the year-end rally in the stock market all create regular seasonal tendencies. These patterns occur across individual equities, commodities, and indices. Statistical analysis of these seasonal trends and patterns can be an extremely important part of a trading approach. In this piece, we combine this seasonal approach with our approach to sector investing in bear markets to provide examples.
When the S&P 500 hit bear market territory on June 13 2022, many investors were left with the bitter taste of disappointment. But this wasn’t happening for the first time: since 1928, the S&P 500 has experienced 26 bear markets.
“Bears” are part of normal market trends. They are relatively short in duration (especially compared with bull markets), and can provide good investment opportunities. They come into existence when a market falls by at least 20% from recent highs.
In our process, we combine balance sheet analysis, sector selection and seasonality. During bear markets, it’s important to concentrate on good balance sheets in “recession-proof” sectors. Most stocks suffer during a recession, but there are sectors that are much more likely to outperform the broad market.
In my previous Seasonal Insights, I have discussed luxury stocks (these insight pieces are available on our website) that have proven their strength during difficult times. It is an industry that resists crises: luxury customers, due to their financial wealth, recover very quickly.
Stocks that tend to outperform during bear markets can be found in defensive sectors, such as consumer staples, utilities and healthcare. Healthcare is a great example of a haven. One of the stocks to consider from this sector is pharmaceutical giant AbbVie. AbbVie is known as a “low-volatility dividend aristocrat.” This posh expression refers to a group of high-quality S&P 500 stocks recognized for delivering at least 25 straight years of dividend growth.
If you decide to enter this trade you should consider its seasonality. Seasonality will offer you the best entry and exit points for a specific stock during the year. It will also prevent you from investing in a name that is entering a seasonally weak period.
Keep in mind that a seasonal chart depicts the average price pattern of a stock over the course of a calendar year. It is calculated over several years (unlike a standard price chart that simply shows stock prices over a specific time period). The horizontal axis depicts the time of the year, while the vertical axis shows the level of the seasonal pattern (indexed to 100). From the chart above, it is clearly visible that the end of October until the end of December, over the past 9 years, have been favorable months for this health stock.
In this time span of 46 trading days (from October 24 until December 30), shares rose on average by almost 14%. Moreover, since 2013 the pattern returns had a winning strike of 100%, meaning that AbbVie Inc generated gain each year since 2013 during the selected time period.
There are also other stocks that are trending high in this sector, such as Pfizer, Eli Lilly, or even insurances like United Health, Anthem and Centene.
Another consequence of a recession is that many consumers will curb their spending. However, consumers still need to buy staples such as food, household goods and hygiene items. Demand for these tend to hold up better than other areas of the economy.
Large food manufacturers such as Tyson Foods, Kellogg and Mondelez International all fall into this category as do large agribusinesses that focus on the raw materials used in food production, such as Bunge or Archer-Daniels Midland.
During difficult times, consumers also tend to look for cheaper alternatives from discount retailers. Even if people shop less during a downturn, they still need to buy staples, and are more likely to treat themselves to a cheaper item at a discount store. Dollar Tree was the best performer in the S&P 500 during the 2008 financial crisis, and was up significantly that year even as the overall market plummeted.
There are also personal care and household product manufacturers such as Colgate-Palmolive and Procter & Gamble. All these stocks suffered a smaller decline than other areas of the stock market during the 2008 financial crash and most of them bottomed out months before the broad market.
But still be aware of the investment timing. Each stock mentioned here has its strong and weak periods during the year. For instance, Kellogg is worth considering after the August – September period of weakness.
Remember, for every bear market, a bull market follows.
Yours sincerely,
Tea Muratovic
Co-Founder and Managing Partner of Seasonax
Guest Author for CMT Association
seasonax.com
Many of the topics and techniques discussed in this post are part of the CMT Associations Chartered Market Technician’s curriculum.
Shared content and posted charts are intended to be used for informational and educational purposes only. The CMT Association does not offer, and this information shall not be understood or construed as, financial advice or investment recommendations. The information provided is not a substitute for advice from an investment professional. The CMT Association does not accept liability for any financial loss or damage our audience may incur.
ABBV to 140?I would love it @ABBV goes down to $140.~ to re-test that neck line. It might not happen good volume coming in but to me it would be stronger if it re-test that level.
#ABBV long ideaHello dear Traders,
Here is my idea for #ABBV
Daily close above the yellow trigger line (previous month high) to enter trade.
We try to anticipate a 2-2 bullish reversal in the weekly chart - price found support at monthly pivot S2 Line
Targets marked in the chart (black lines)
Invalidation level marked with red line
Please feel free to ask any question in comments. I will try to answer all! Thank you
Stock movement looks familiar.Will the pattern hold?
Also, Botox rival, Revance Therapeutics, got approved. Longer lasting than Botox. Remains to be seen if it can eat into ABBV's market share.
AbbVie Inc, ABBV NYSE 4HNYSE:ABBV
rsi in the oversold territory, which is starting to reverse to the bull side,
flipped bullish on a micro timescale, falling wedge, breaking out to the upside,
first target 140.75, then possible retest before 146.26.
we've been in this long term downtrend channel since April 2022, I expect to break out of it, once
we test 150.36 flip it as support then go for for 175.89 previous April top. fundamentals and news tend
to effect this stock a lot, so with positive momentum and good news. bullish times could be ahead.
Bear scenario is we test 125 before a full reset.
For the current quarter, AbbVie is expected to post earnings of $3.59 per share, indicating a change of +7.8% from the year-ago quarter. The Zacks Consensus Estimate has changed -2.2% over the last 30 days.
The consensus earnings estimate of $13.90 for the current fiscal year indicates a year-over-year change of +9.5%. This estimate has changed +0.2% over the last 30 days.
all this is just my opinion , none of what I say should be taken as financial advice. DYOR
Regards Percy
ABBV ShortBounce back to supply Zone, Zone Confirmation
Trendline break
Earning: 7/29/2022 Est. 3.43
Short 152
Stop 160
Target 137, 122
Risk management is much more important than a good entry point.
I am not a PRO trader.
In my trading plan, the Max Risk of each short term trade should be less than 1% of an account.
abbv stock again bullish trend abbv stock again bullish trend markete makes a lowr low and divergence makes a high and high
ABBV- Bull Flag Pattern What call option is suggested?NYSE:ABBV
ABBV could breakout from a bull flag pattern on the daily chart
It is sitting on the support of a triple bottom, and an 8% upside
to the POC of the volume profile. as well as a 14% upside to
the high 3-4 months ago.
What would be a good option 5-6 months out to capture
the anticipated uptrend over that time?
